Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00342485 · ClinicalTrials.gov registry record
In Vitro Study of Peripheral Blood Mononuclear Cell Function in Healthy Individuals and Patients
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 5,000
- Enrollment target
NCT00342485: Completed study, sponsored by National Cancer Institute (NCI).
NCT00342485 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 5,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00342485 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 5,000 participants
- Enrollment target
Study Summary
Peripheral blood mononuclear cells (PBMC) will be collected from healthy volunteers and patients who present with different diseases that involve or implicate the immune system dysregulation (HIV infection, autoimmune diseases and cancer). These PBMC will be studied in vitro for a number of functional parameters, including generating soluable factors that inhibit HIV infection, developing patterns of immune dysregulation, and inducing apoptotic T cell death. The purpose of such studies is to obtain insight into the mechanisms of natural resistance to viral infections, AIDS pathogenesis, and disease-induced immune dysregulation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 1993-04-12 |
| Est. Completion | 2008-03-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00342485
The ClinicalTrials.gov registry entry for NCT00342485 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00342485 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00342485 about?
NCT00342485 is a clinical study titled "In Vitro Study of Peripheral Blood Mononuclear Cell Function in Healthy Individuals and Patients". Peripheral blood mononuclear cells (PBMC) will be collected from healthy volunteers and patients who present with different diseases that involve or implicate the immune system dysregulation (HIV infection, autoimmune diseases and cancer). These PBMC will be studied in vitro for a number of function...
What is the current status of trial NCT00342485?
This trial is currently completed. The enrollment target is 5,000 participants. The study started on 1993-04-12. Estimated completion is 2008-03-03.
Who is sponsoring clinical trial NCT00342485?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.